IP Library Granted Patent US 11,268,135
Granted Patent B2
US 11,268,135 · App. 16/300,469 · Granted Mar 8, 2022

Compositions and methods for identifying, quantifying, and/or characterizing an analyte

Inventor: Nicolas Arab (Austin, TX)
Assignee: PATTERN BIOSCIENCE, INC.
C12Q1/6818C12Q1/68G01N33/542
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,268,135
App. No.
16/300,469
Granted
Mar 8, 2022
Kind
B2
Abstract

Embodiments of this invention are directed towards the sensitive, fast, and accurate identification and/or characterization of a single cell or bacterium, particularly phenotypic characterization. Certain aspects of the invention include assays that include functional nucleic acid probes (FNAPs). FNAPs can be used to generate deoxyribozyme cleavage cascades (DRCC) initiated by activation of a FNAP resulting in a detectable signal from a single cell.

Claims (44)

1. A nucleic acid probe composition comprising a first functional nucleic acid probe comprising:

a first end coupled to a quencher or a fluorophore, wherein the quencher or fluorophore is coupled directly to the first end or is coupled to the first end by a first terminal linker;

a second end coupled to a fluorophore or a quencher, wherein the quencher or fluorophore is coupled directly to the second end or is coupled to the second end by a second terminal linker; and

from the first end to the second end:

(a) a first substrate recognition sequence;

(b) a first catalytic core sequence;

(c) a second substrate recognition sequence that is also operable as a landing sequence for an enzymatic sequence;

(d) a cleavage site that can be cleaved by the enzymatic sequence;

(e) a second landing sequence for the enzymatic sequence;

(f) a linker comprising a target binding region or a spacer region comprising a target binding region; and

(g) a first inhibitory sequence that is complementary to all or some of the first substrate recognition sequence;

wherein (1) the first inhibitory sequence or (2) the first inhibitory sequence and the second terminal linker sequesters the first substrate recognition sequence when the cleavage site is uncleaved.

2. The composition of claim 1 , wherein the first substrate recognition sequence, the first catalytic core sequence, and the second substrate recognition sequence form a nucleic acid enzyme (NAE).

3. The composition of claim 2 , wherein the NAE is a 10-23 DNAzyme, an 8-17 DNAzyme, or a G-quadruplex DNAzyme.

4. The composition of claim 1 , wherein the target binding region comprises an aptamer.

5. The composition of claim 1 , further comprising a second functional nucleic acid probe comprising:

a first end coupled to a quencher or a fluorophore, wherein the quencher or fluorophore is coupled directly to the first end or is coupled to the first end by a first terminal linker; and

from the first end to a second end of the second functional nucleic acid probe:

(i) first substrate recognition sequence;

(ii) a catalytic core sequence;

(iii) a second substrate recognition sequence that is also operable as a landing sequence for an enzymatic sequence; and

(iv) a cleavage site that can be cleaved by the enzymatic sequence of (iii).

6. A method for analyzing target analytes, comprising:

(a) providing a plurality of partitions with at least one partition comprising at least one target analyte, a first functional nucleic acid probe of claim 1 , an oligonucleotide probe substrate, and constituents required for analyte binding, substrate binding, and substrate catalysis;

(b) incubating the partitions with the first functional nucleic acid probe, probe substrate, and constituents wherein at least one probe binds to the target analyte;

(c) activating a nucleic acid enzyme within the first functional nucleic acid probe that continuously catalyzes a reaction throughout the incubation, whereby the product of the reaction releases a detectable label;

(d) producing an accumulation of detectable label within the partition; and

(e) detecting the detectable label.

7. The method of claim 6 , wherein the partitions comprise droplets in an immiscible fluid.

8. The method of claim 7 , wherein the droplets are arranged in a static two-dimensional array monolayer for incubation and detection.

9. The method of claim 8 , wherein the immiscible fluid is a fluorocarbon comprising a fluorosurfactant.

10. The method of claim 8 , wherein the droplet partitions are generated using Laplace pressure gradients or shear stress.

11. The method of claim 8 , wherein detection is performed using a camera comprising a plurality of emission filters and magnifications or a plurality of light emitting diodes (LEDs) combined with a plurality of excitation filters.

12. The method of claim 6 , wherein the nucleic acid enzyme is an endonuclease.

13. The method of claim 12 , wherein the oligonucleotide probe substrate is labeled with a fluorophore and a quencher wherein the fluorophore is separated from the quencher after endonucleatic cleavage.

14. The method of claim 13 , wherein the oligonucleotide probe substrate is a stem-loop structure.

15. The method of claim 12 , wherein the first functional nucleic acid probe comprises an aptazyme, or an allosteric aptazyme.

16. The method of claim 12 , wherein the nucleic acid enzyme is a 10-23 DNAzyme or derivative thereof, or an 8-17 DNAzyme or derivative thereof, or a G-quadruplex DNAzyme or derivative thereof.

17. The method of claim 6 , wherein the partitions further comprise an environmental stressor.

18. The method of claim 17 , wherein the environmental stressor is an antimicrobial.

19. The method of claim 6 , wherein the oligonucleotide probe substrate is a cleavage-activated catalytic substrate comprising a nucleic acid enzyme encoded within an enzymatic sequence region that is partially bound to an inhibiting sequence region and when the substrate is cleaved, the inhibiting sequence region is severed from the enzymatic sequence region, liberating the nucleic acid enzyme encoded within the enzymatic sequence region.

20. The method of claim 19 , wherein an allosteric sequence region in the at least one probe binds to the target analyte, and wherein an exponential deoxyribozyme ribonuclease cleavage cascade is initiated by the liberated nucleic acid enzyme, wherein the liberated nucleic acid enzyme:

(a) binds to a loop region of the first functional nucleic acid probe; and

(b) catalyzes the cleavage of the first functional nucleic acid probe, bypassing the allosteric sequence region by severing the inhibiting sequence region from the enzymatic sequence region.

Assignments (4)
CHANGE OF NAME Recorded Aug 25, 2020
From: KLARIS CORPORATION
To: PATTERN BIOSCIENCE, INC.
Reel/Frame 053597/0101 →
CHANGE OF NAME Recorded Jul 15, 2019
From: VIASPHERE, LLC,
To: KLARIS CORPORATION
Reel/Frame 049751/0194 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED APPLICATION NO. 16/200,469 PREVIOUSLY RECORDED ON REEL 048270 FRAME 0932. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Mar 14, 2019
From: ARAB, NICOLAS
To: VIASPHERE, LLC
Reel/Frame 048598/0952 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2019
From: ARAB, NICOLAS
To: VIASPHERE, LLC
Reel/Frame 048270/0932 →
Continuity (2)
Provisional Application 62334191 · May 10, 2016
Related Publication 20190144925A1 · May 16, 2019